Tag: Postmarket studies

CHC_FDA-Regulatory Images2

09/20/2021

BMJ Study: Accelerated Approval Drugs Retain Status Despite Lack of Benefit

News Sharpless (1)

05/06/2019

FDA Leaders Highlight Issues, Opportunities of Real-world Data Post-marketing